Steqeyma Prices, Coupons, Copay Cards & Patient Assistance
Steqeyma (ustekinumab) is a member of the interleukin inhibitors drug class and is commonly used for Crohn's Disease, Crohn's Disease - Active, Plaque Psoriasis, and others.
The cost for Steqeyma (stba 5 mg/mL) intravenous solution is around $334 for a supply of 26 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Steqeyma prices
Intravenous Solution
stba 5 mg/mL
Steqeyma intravenous solution
from $334.19
for 26 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 26 milliliters | $12.85 | $334.19 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Steqeyma Coupons, Copay Cards and Rebates
Steqeyma offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Steqeyma Celltrion Cares Co-Pay Assistance Program
Eligible commercially insured patients may pay $0 per dose.
- Applies to:
- Steqeyma
- Number of uses:
- Per length of program
Form more information phone: 877-812-6662 or Visit website
Patient Assistance & Copay Programs for Steqeyma
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Steqeyma (ustekinumab-stba) Injection: IV or Subcutaneous
More information please phone: 866-316-7263 Visit Website
Provider: Celltrion CONNECT Steqeyma Free Sharps Disposal
Eligibility requirements:- Not applicable
- Not applicable
- Medically appropriate condition/diagnosis
- US residency requirements are not specified.
- Patient enrolls to receive a free sharps container.
- Steqeyma (ustekinumab-stba) Disposal Container
More information please phone: 855-216-7657 Visit Website
Provider: Celltrion CONNECT Steqeyma Patient Assistance Program
Eligibility requirements:- Must be uninsured
- At or below 400% of FPL
- FDA-approved diagnosis
- Must be residing in the US or Puerto Rico
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Steqeyma (ustekinumab-stba) Injection: IV or Subcutaneous
More information please phone: 877-812-6662 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Vtama
Vtama (tapinarof) is a steroid-free, once-daily cream used to treat plaque psoriasis and atopic ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Medrol
Medrol is used for allergic rhinitis, asthma, asthma, acute, asthma, maintenance, congenital ...
Mesalamine
Mesalamine is used to treat mild to moderate ulcerative colitis and prevent the symptoms of ...
Prednisolone
Prednisolone is used to treat many different inflammatory conditions such as arthritis, lupus, and ...
Hydrocortisone topical
Hydrocortisone cream is used to treat eczema, dermatitis, psoriasis, hemorrhoids, insect bites or ...
More about Steqeyma (ustekinumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Other brands
Stelara, Selarsdi, Pyzchiva, Wezlana, ... +3 more
Professional resources
Other brands
Stelara, Selarsdi, Pyzchiva, Wezlana, ... +2 more
